http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation
-
Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences
-
Greenwich LifeSciences builds internal clinical operations team
-
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
-
Greenwich LifeSciences expands breast cancer trial to Romania
-
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
-
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
-
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
-
Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Greenwich LifeSciences (GLSI) Provides Global Update on FLAMINGO-01
-
Greenwich LifeSciences Provides Global Update on FLAMINGO-01
-
Greenwich LifeSciences (GLSI) Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
-
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
-
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
-
Greenwich LifeSciences (GLSI) Provides Update on Open Label Safety Data from FLAMINGO-01
-
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
-
Greenwich LifeSciences (GLSI) Provides Update on Open Label HLA Data from FLAMINGO-01
-
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
-
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
-
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
-
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
-
Greenwich LifeSciences (GLSI) Provides Update on Commercial Manufacturing
-
Greenwich LifeSciences Provides Update on Commercial Manufacturing
-
Greenwich LifeSciences (GLSI) Announces Partnership with GBG in Germany for Flamingo-01
-
Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
-
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
-
Greenwich LifeSciences Partners with GIM in Italy
-
Greenwich LifeSciences Provides Update on Corporate Events
-
Greenwich LifeSciences (GLSI) Provides Update on Expansion of Flamingo-01 into Spain
-
Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
-
Greenwich LifeSciences (GLSI) to Rejoin Russell 2000 Index
-
Greenwich LifeSciences Set to Join Russell 2000 Index Again
-
Greenwich LifeSciences (GLSI) Announces 175K Private Placement at $14.30/sh
-
Greenwich LifeSciences Announces $2.5 Million Private Placement
-
Greenwich LifeSciences (GLSI) Extends Lock-up of Directors and Officers to June 30, 2025
-
Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
-
Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
-
Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
-
Greenwich LifeSciences (GLSI) Announces Flamingo-01 Phase III Clinical Trial Approved to Expand into Five EU Countries
-
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
-
Greenwich LifeSciences (GLSI) Announces Flamingo-01 Manufacturing & Protocol Accepted by EU Regulators
-
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
-
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
-
Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial
-
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
-
Greenwich LifeSciences (GLSI) Extends Lock-up of Directors and Officers to End of 2024
-
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
-
Greenwich LifeSciences (GLSI) Issues Year End Update
-
Greenwich LifeSciences Provides Year End Update
-
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023
